Results 171 to 180 of about 30,879 (201)

The distribution and the clinical importance of MUC5B and TERT variants in Turkish patients with idiopathic pulmonary fibrosis. [PDF]

BMC Pulm Med
Ödemiş A, Öğüş AC, Toylu A, Dirol H, Çilli A, Özbudak Ö, Altıok Clark Ö, Özdemir T.   +7 more
europepmc   +1 more source

Low diffusing capacity for carbon monoxide in chronic thromboembolic pulmonary hypertension: a biomarker for microvascular disease?

Christian Gerges, Hiromi Matsubara, Iréne Lang   +2 more
openalex   +1 more source

Clinical Characteristics and Risk Factors for Progressive Pulmonary Fibrosis in Primary Sjögren's Syndrome: A Case-Control Study. [PDF]

Risk Manag Healthc Policy
Diao J, Qiao L, Duan X, Hui M, Li M, Zhao Y, Zeng X, Xu D.   +7 more
europepmc   +1 more source

Use of speleotherapy in patients with post-COVID-19 syndrome. [PDF]

Front Med (Lausanne)
Garbsch R, Kotewitsch M, Schäfer H, Teschler M, Mooren FC, Schmitz B.   +5 more
europepmc   +1 more source

A case of antisynthetase syndrome with interstitial lung disease in pregnancy. [PDF]

Obstet Med
Park E, Munro K, Wickremasinghe M, Frise CJ.   +3 more
europepmc   +1 more source

Erratum: "¹H-NMR urine metabolomic fingerprint for severity discrimination in pulmonary sarcoidosis" Florence Jeny, Mohamed Nawfal Triba, Simon Chauveau, Dominique Valeyre, Sabrina Mokhtari, Hilario Nunes, Jean-Francois Bernaudin and Philippe Savarin. <i>ERJ Open Res</i> 2025; 11: 00763-2024. [PDF]

ERJ Open Res
europepmc   +1 more source